---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-247855"
form_type: "8-K"
ticker: "ORIC"
cik: "0001796280"
company_name: "Oric Pharmaceuticals, Inc."
filed_at: "2021-08-16T23:59:59+00:00"
generated_at: "2026-06-29T10:15:08.354145+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ORIC appoints Steven Hoerter as director; Peter Svennilson resigns from board

## Summary
- Steven L. Hoerter, CEO of Deciphera Pharmaceuticals, appointed as Class II director effective Aug 13, 2021; will serve on Audit Committee.
- Peter Svennilson resigned voluntarily as part of planned reduction of public board commitments; had served over six years since TCG's founding investment.
- New director Hoerter receives annual retainer of $35,000 plus $7,500 for Audit Committee; granted option for 33,250 shares vesting monthly over 3 years.
- Lease amendment expands facility by ~340 sq ft, extends term to May 2028, and landlord contributes $1,514,835 toward improvements.

## SEC filing metadata
- accession: 0001193125-21-247855
- form_type: 8-K
- ticker: ORIC
- cik: 0001796280
- company_name: Oric Pharmaceuticals, Inc.
- filed_at: 2021-08-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1796280/000119312521247855/0001193125-21-247855-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1796280/000119312521247855/d127312d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-247855
- JSON: https://secwatch.observer/filing/0001193125-21-247855.json
- Plain text: https://secwatch.observer/filing/0001193125-21-247855.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.